IVF success is not random. The outcome of each cycle is determined by a combination of biological factors — some fixed, some improvable — that interact in complex ways. Understanding these factors helps patients make informed decisions, set realistic expectations, and take targeted action to improve their chances.
About this guide: For patients considering or undergoing IVF at Mother Hospitals, Boduppal, Hyderabad. For age-specific success rate data, see our IVF Success Rate guide.
The Relative Impact of IVF Success Factors
Not all factors carry equal weight. Below is the relative impact of the major determinants of IVF success, ranked by clinical evidence:
Maternal age / Egg quality
Critical
Embryo quality (grade)
Very high
PGT-A chromosomal testing
High
Endometrial receptivity / lining
High
Progesterone support protocol
High
Sperm quality (DNA fragmentation)
Moderate
BMI (body weight)
Moderate
Smoking / alcohol
Significant
Thyroid / Vitamin D status
Significant
Stress / psychological state
Modest
Factor 1: Maternal Age and Egg Quality Cannot be changed
Age is the dominant determinant of IVF success because egg quality — specifically chromosomal accuracy — declines progressively after 32, accelerating after 37. This is not about ovarian reserve (how many eggs) but egg quality (whether the eggs produce chromosomally normal embryos).
| Age | Est. Live Birth Rate / Transfer | Chromosomal Abnormality Rate in Eggs | Best Strategy |
|---|---|---|---|
| Under 30 | 45–55% | ~15–20% | Standard IVF; freeze surplus embryos |
| 30–34 | 40–48% | ~25–30% | Standard IVF or PGT-A for ≥3 blastocysts |
| 35–37 | 30–38% | ~35–45% | PGT-A strongly considered; frozen transfer preferred |
| 38–40 | 20–28% | ~50–60% | PGT-A recommended; banking cycles may be needed |
| 41–42 | 12–18% | ~65–75% | PGT-A; donor egg discussion appropriate |
| 43–44 | 6–10% | ~75–85% | Donor egg IVF offers significantly higher success rates |
| 45+ | 1–3% (own eggs) | >85% | Donor egg IVF recommended for most patients |
Why age matters more than AMH: AMH (Anti-Müllerian Hormone) measures how many eggs remain — ovarian quantity. Age determines egg quality — the chromosomal accuracy of those eggs. A 42-year-old with high AMH still has age-related egg quality issues. A 32-year-old with low AMH has fewer eggs but better quality. This is a critical distinction that affects treatment strategy.
Factor 2: Embryo Quality — Blastocyst Grading Partially improvable
Embryo quality is assessed by blastocyst grading — morphological evaluation of how the embryo looks at Day 5. The standard grading system evaluates three parameters:
- Expansion level (1–6): how expanded and hatching the blastocyst is (higher = better)
- Inner Cell Mass (ICM): A (many cells, tightly packed) / B (several cells, loosely grouped) / C (very few cells)
- Trophectoderm (TE): A (many cells, cohesive) / B (few cells, loose) / C (very few cells)
4AA / 5AA / 6AA
60–70%
Best grade — highest implantation rates. ICM and TE both excellent.
4AB / 5AB / 4BA
50–60%
Very good grade — one parameter excellent, other good.
3BB / 4BB
35–50%
Good grade — clinically acceptable implantation rates.
3BC / 3CB
20–35%
Fair — transferable but lower success; freeze if better embryos available.
2CC / 3CC
8–15%
Lower grade — transfer in absence of better options; some do implant.
Important caveat: Embryo grade is morphological — it describes appearance, not chromosomal normality. A visually perfect 5AA embryo can be chromosomally abnormal (aneuploid) and fail to implant. This is why PGT-A testing is used to add a chromosomal layer to grading in appropriate cases — not to replace grading, but to select from visually good embryos.
Factor 3: PGT-A — Preimplantation Genetic Testing Optional upgrade
PGT-A (previously known as PGS — Preimplantation Genetic Screening) tests embryos for all 23 chromosome pairs before transfer. The goal: only transfer chromosomally normal (euploid) embryos.
| Without PGT-A | With PGT-A (euploid embryo only) | |
|---|---|---|
| Implantation rate | ~40–50% (Day-5, good grade) | ~65–70% (euploid confirmed) |
| Miscarriage rate | ~15–25% (age-dependent) | ~5–10% (largely age-independent) |
| Multiple implantation failure rate | Higher (aneuploid embryos fail silently) | Lower |
| Who benefits most | Women 37+, recurrent implantation failure, recurrent miscarriage | |
| Who may not need it | Women under 35 with good-quality embryos and first IVF cycle | |
PGT-A is available at Mother Hospitals as part of the advanced IVF options. The decision to use PGT-A is made jointly by Dr. Prashanthi Reddy and the patient — it is not right for every patient but is strongly recommended for specific groups.
Factor 4: Endometrial Receptivity — The Window of Implantation Testable & optimisable
Even a perfect euploid embryo cannot implant in an unreceptive uterus. The endometrium (uterine lining) has a specific window of peak receptivity — typically a 24–48 hour period approximately 120 hours (5 days) after starting progesterone. This window is called the Window of Implantation (WOI).
| Endometrial Factor | Optimal Range / Finding | If Abnormal |
|---|---|---|
| Endometrial thickness at transfer | >8 mm (ideal ≥10 mm) | <7 mm significantly reduces implantation; ERA test, growth factors, extended estrogen protocol considered |
| Endometrial pattern | Trilaminar (triple-line) pattern on ultrasound | Non-trilaminar pattern associated with lower implantation rates |
| Window of Implantation (WOI) | Standard: 120 hours after progesterone start | ~20–30% of recurrent implantation failure patients have displaced WOI — detected by ERA test |
| Uterine cavity | Normal shape, no polyps, no fibroids distorting cavity | Hysteroscopy to remove polyps, submucosal fibroids, or intrauterine adhesions before transfer |
| Chronic endometritis | Absent | Chronic uterine inflammation (diagnosed by endometrial biopsy) reduces implantation; antibiotic treatment improves outcomes |
ERA test at Mother Hospitals: The Endometrial Receptivity Analysis (ERA) test is available for patients with recurrent implantation failure (≥2 failed transfers with good-quality embryos). It identifies the personalised WOI and guides the exact timing of subsequent embryo transfers. ERA-guided personalised transfers significantly improve implantation rates in WOI-displaced patients.
Factor 5: Progesterone Support Protocol Optimisable
Progesterone supplementation after IVF embryo transfer is not optional — it is essential. The luteal phase after egg retrieval is deficient in natural progesterone production, and the endometrium requires progesterone support to maintain receptivity.
| Route | Advantages | Considerations |
|---|---|---|
| Vaginal pessaries (micronised progesterone) | High local endometrial concentration; gold-standard route; supported by most evidence | Discharge; requires consistent use 2–3× daily |
| Progesterone gel (Crinone) | Once-daily application; less discharge than pessaries | Higher cost |
| Progesterone injection (IM) | Systemic delivery; higher blood levels; used in women with pessary absorption concerns | Pain at injection site; less local endometrial concentration |
| Oral progesterone | Convenient | Lower efficacy than vaginal route; first-pass liver metabolism; not preferred in IVF |
Never stop progesterone without instruction. The timing of progesterone withdrawal is precisely controlled — typically tapered from Week 10 after blood level confirmation. Premature cessation is associated with increased miscarriage risk. If you have side effects from your progesterone formulation, discuss switching routes with Dr. Prashanthi Reddy rather than reducing or stopping.
Factor 6: Sperm Quality and DNA Fragmentation Partially improvable
Male factor contributes to approximately 40–50% of infertility cases. In IVF with ICSI, even severe male factor can be bypassed for fertilisation — but sperm quality still affects embryo development and pregnancy outcomes.
| Sperm Parameter | Impact on IVF | What Helps |
|---|---|---|
| DNA Fragmentation Index (DFI) | DFI >15% reduces blastocyst rates; DFI >25% significantly increases miscarriage risk | Antioxidants (CoQ10, Vitamin C, E) for 3 months; TESA (surgical sperm retrieval) if DFI very high; varicocele repair if identified |
| Motility (asthenospermia) | Affects fertilisation — bypassed by ICSI | Carnitine, CoQ10, zinc supplementation; lifestyle (BMI, no smoking) |
| Morphology (teratospermia) | Affects fertilisation rate — ICSI mitigates but does not eliminate | Antioxidant treatment; 3-month cycle of supplements |
| Count (oligospermia) | Bypassed by ICSI; critical if azoospermia | TESA/PESA/micro-TESE for azoospermia — available at Mother Hospitals |
The 3-month window: Sperm production takes approximately 72–90 days (3 months) from start to finish. This means that any sperm quality improvements from lifestyle changes or antioxidant supplementation take approximately 3 months to fully manifest in ejaculated sperm. Starting treatment at least 3 months before the IVF cycle is recommended.
Factor 7: Lifestyle Factors — What You Can Change Directly improvable
| Factor | Effect on IVF Success | Target |
|---|---|---|
| BMI | BMI >30: implantation rate reduced by ~30%; stimulation dose higher; OHSS risk higher; egg quality lower. BMI <18.5: irregular ovulation; poor response | BMI 20–25 optimal for IVF. Losing even 5–10% of body weight improves outcomes. |
| Smoking | Reduces ovarian reserve, egg quality, and implantation rates by 20–30%. Increases miscarriage risk. | Stop smoking entirely — ideally 3 months before IVF start |
| Alcohol | Even moderate drinking (3–4 units/week) reduces IVF success rates by ~10–13% in women. Zero is optimal. | No alcohol from at least 3 months before IVF start |
| Vitamin D | Vitamin D deficiency (very common in Hyderabad) is associated with lower implantation rates, higher miscarriage risk, and gestational diabetes in pregnancy | Target serum 25-OH Vitamin D >50 nmol/L before IVF. Supplement as needed. |
| Thyroid (TSH) | TSH above 2.5 reduces implantation rates and increases miscarriage risk. Hypothyroidism is extremely common in women in Telangana. | TSH below 2.5 before embryo transfer. Treat with levothyroxine if elevated. |
| Folic acid | Reduces neural tube defect risk; some evidence supports improved implantation with methylfolate supplementation in MTHFR gene variant carriers | 5 mg folic acid daily from 3 months before IVF start |
| Exercise | Moderate exercise (150 min/week) improves insulin sensitivity (benefits PCOS patients), BMI, and stress. High-intensity exercise reduces IVF success in some studies. | Walking, yoga, light cycling — avoid extreme exercise during stimulation and luteal phase |
What Mother Hospitals Does Differently for IVF Success
- Individualised stimulation protocols: Tailored FSH/LH dosing based on AMH, AFC, age, and PCOS/poor-responder status — not a one-size-fits-all approach
- Blastocyst culture (Day 5): All embryos cultured to blastocyst stage where possible — better selection than Day-3 transfer
- Freeze-all strategy for OHSS risk: When OHSS risk is elevated, all embryos are frozen and transferred in a subsequent programmed frozen embryo transfer (FET) cycle — optimising the endometrium
- ERA testing for recurrent implantation failure: Available for patients with ≥2 failed transfers with good-quality embryos
- Hysteroscopy before transfer: Uterine cavity assessment before first transfer in patients with previous failures, abnormal uterus, or polyps
- PGT-A counselling: Individual discussion of PGT-A benefit for each patient based on age and embryo availability
- Luteal phase optimisation: Personalised progesterone protocol with blood level monitoring
- Seamless transition to pregnancy care: All IVF patients transition directly to Dr. Prashanthi Reddy's antenatal care — no change of doctor, no loss of history
Frequently Asked Questions — IVF Success Factors
What is the most important factor for IVF success?
Maternal age at egg collection — because egg quality (chromosomal accuracy) declines with age. Live birth rates per transfer range from ~50% in women under 30 to ~2% in women over 44 using their own eggs. PGT-A testing of embryos and donor egg IVF can largely overcome the age factor.
Does embryo quality determine IVF success?
Significantly. Top-grade blastocysts (4AA, 5AA) have implantation rates of 60–70%. Lower-grade embryos (3BB, 4BB) achieve 35–50%. Embryo grade is morphological — it describes appearance, not chromosomal normality. PGT-A adds the chromosomal layer to grading.
What is PGT-A and does it improve IVF success?
PGT-A tests embryos for all chromosome pairs before transfer. Euploid (normal) embryos achieve ~65–70% implantation rates and only ~5–10% miscarriage rate regardless of age. Most beneficial for women over 37, recurrent implantation failure, and recurrent miscarriage patients.
What is the ERA test and who needs it?
ERA (Endometrial Receptivity Analysis) identifies each woman's personalised Window of Implantation — the 24–48 hour window when the endometrium is most receptive. About 20–30% of women with recurrent implantation failure have a displaced window (earlier or later than standard). An ERA-guided personalised transfer significantly improves implantation in these women.
What lifestyle changes improve IVF success?
Achieving BMI 20–25, stopping smoking entirely (3 months before IVF), stopping alcohol, folic acid 5 mg daily, correcting Vitamin D deficiency (extremely common in Hyderabad), ensuring TSH below 2.5, and antioxidant supplements for sperm quality (CoQ10, Vitamin C/E) — all have evidence for improving IVF outcomes.
Does male factor affect IVF pregnancy success?
Yes — especially sperm DNA fragmentation (DFI). DFI above 25% is associated with lower blastocyst rates and higher miscarriage risk after IVF. Antioxidant treatment for 3 months, varicocele repair if present, and TESA for surgical sperm retrieval can improve outcomes in high-DFI men.
Maximising Your IVF Success at Mother Hospitals
Individualised stimulation, blastocyst culture, ERA testing, PGT-A counselling, and luteal phase optimisation — all under one team in Boduppal, Hyderabad. All-inclusive IVF from ₹99,000.